March 26, 2018 / 8:55 PM / a month ago

BRIEF-RXi Pharmaceuticals Qtrly Loss Per Share $0.84

March 26 (Reuters) - RXi Pharmaceuticals Corp:

* RXI PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

* RXI PHARMACEUTICALS CORP - QTRLY LOSS PER SHARE $0.84 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below